Avadel Pharmaceuticals
 | The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (March 2014) |
 | |
| Company type | Public |
|---|---|
| Nasdaq: AVDL | |
| Industry |
|
| Founded | 1990 |
| Headquarters | , Ireland |
Key people |
|
| Revenue | $ 150.2M (Dec31, 2016)[1] |
| Website | www |
Avadel Pharmaceuticals plc, is a specialty pharmaceutical company. Avadel markets products in the hospital and primary care spaces. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France.[2]
The company was founded as Flamel Technologies SA in Lyon, France in 1990.[3]
The company acquired Éclat Pharmaceuticals of St. Louis, Missouri in March 2012.[4][5]
On 8 February 2016, the company acquired FSC Holdings, LLC, which included its wholly owned subsidiaries FSC Pediatrics, Inc., FSC Therapeutics, LLC, and FSC Laboratories, Inc.[6]
On 3 January 2017, Flamel, Éclat, and FCS Pediatrics became Avadel Pharmaceuticals plc after the Company completed a cross-border merger from France to Ireland.[7]
In 2019, Mike Anderson, CEO of Avadel Pharmaceuticals has resigned, and Gregory Divis, COO of the company was appointed as his temporary successor. Meanwhile, Craig Stapleton, chairman of the Dublin-headquartered Avadel, has also stepped down. That same year, the company filed for Chapter 11 bankruptcy.[8][9]
In May 2023, Avadel Pharmaceuticals received FDA approval for Lumryz, an extended-release oral suspension of sodium oxybate.[10]
References[edit]
- ^ "Company Key Statistics".
- ^ "Investor Home". investors.avadel.com. Retrieved 26 June 2017.
- ^ "Presentations | Investors | Avadel Pharmaceuticals". investors.avadel.com. Retrieved 17 July 2017.
- ^ "About Us". eclatpharma.com. Retrieved 29 December 2014.
- ^ "Flamel Technologies Announces Acquisition of Éclat Pharmaceuticals". businesswire.com. 14 March 2012. Retrieved 29 December 2014.
- ^ "Flamel Technologies Acquires FSC Pediatrics". marketwired.com. 8 February 2016. Retrieved 7 March 2017.
- ^ "Flamel Technologies Completes Cross-Border Merger and Becomes Avadel Pharmaceuticals plc". globenewswire.com (Press release). 3 January 2017. Retrieved 7 March 2017.
- ^ "Avadel chief executive resigns suddenly". The Irish Times. 3 January 2019. Archived from the original on 3 January 2019. Retrieved 30 October 2020.
- ^ "Avadel Specialty Pharmaceuticals files for Chapter 11 bankruptcy". Wall Street Journal. 7 February 2019. Retrieved 24 February 2023.
- ^ Brooks, Megan. "FDA OKs Once-Nightly Sodium Oxybate for Narcolepsy". Medscape. Retrieved 14 July 2023.
External links[edit]
| International | |
|---|---|
| National | |
  | This Irish company article is a stub. You can help Wikipedia by expanding it. |